NCT05551104View on ClinicalTrials.gov

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

PHASE3RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Postpartum ComplicationMaternal HypertensionHigh Blood Pressure
Interventions
DRUG

Oral Nifedipine

Administration of oral nifedipine to control postpartum hypertension.

DRUG

Oral Labetalol

Administration of oral labetalol to control postpartum hypertension.

Trial Locations (1)

92350

RECRUITING

Loma Linda University Health, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER